Quest Diagnostics Incorporated
DGX
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 3 days ago • DGX
City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
Zacks Investment Research • 4 days ago • DGX
Here's How Quest Diagnostics Is Placed Ahead of Q1 Earnings
Zacks Investment Research • 5 days ago • DGX
Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research • 19 days ago • DGX
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
PRNewsWire • about a month ago • DGX
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.